Cargando…
肺微乳头腺癌病理学及分子学特征研究进展
Lung micropapillary adenocarcinoma is characterized by frequent metastasis, lymph node infiltration, high recurrence rate and low overall survival rate as a high-grade lung adenocarcinoma. Special oncogenic pathway is activated and immune microenvironment is established in this subtype of tumor. Thi...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679217/ https://www.ncbi.nlm.nih.gov/pubmed/33203200 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.37 |
_version_ | 1783612297423355904 |
---|---|
collection | PubMed |
description | Lung micropapillary adenocarcinoma is characterized by frequent metastasis, lymph node infiltration, high recurrence rate and low overall survival rate as a high-grade lung adenocarcinoma. Special oncogenic pathway is activated and immune microenvironment is established in this subtype of tumor. This article reviews the Pathological phenomena and molecular features of micropapillary adenocarcinoma studied in recent years, aiming to deepen the understanding of micropapillary lesions and lay the foundation for formulating specific treatment strategies. |
format | Online Article Text |
id | pubmed-7679217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-76792172020-12-03 肺微乳头腺癌病理学及分子学特征研究进展 Zhongguo Fei Ai Za Zhi 综述 Lung micropapillary adenocarcinoma is characterized by frequent metastasis, lymph node infiltration, high recurrence rate and low overall survival rate as a high-grade lung adenocarcinoma. Special oncogenic pathway is activated and immune microenvironment is established in this subtype of tumor. This article reviews the Pathological phenomena and molecular features of micropapillary adenocarcinoma studied in recent years, aiming to deepen the understanding of micropapillary lesions and lay the foundation for formulating specific treatment strategies. 中国肺癌杂志编辑部 2020-11-20 /pmc/articles/PMC7679217/ /pubmed/33203200 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.37 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/. |
spellingShingle | 综述 肺微乳头腺癌病理学及分子学特征研究进展 |
title | 肺微乳头腺癌病理学及分子学特征研究进展 |
title_full | 肺微乳头腺癌病理学及分子学特征研究进展 |
title_fullStr | 肺微乳头腺癌病理学及分子学特征研究进展 |
title_full_unstemmed | 肺微乳头腺癌病理学及分子学特征研究进展 |
title_short | 肺微乳头腺癌病理学及分子学特征研究进展 |
title_sort | 肺微乳头腺癌病理学及分子学特征研究进展 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679217/ https://www.ncbi.nlm.nih.gov/pubmed/33203200 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.37 |
work_keys_str_mv | AT fèiwēirǔtóuxiànáibìnglǐxuéjífēnzixuétèzhēngyánjiūjìnzhǎn AT fèiwēirǔtóuxiànáibìnglǐxuéjífēnzixuétèzhēngyánjiūjìnzhǎn AT fèiwēirǔtóuxiànáibìnglǐxuéjífēnzixuétèzhēngyánjiūjìnzhǎn AT fèiwēirǔtóuxiànáibìnglǐxuéjífēnzixuétèzhēngyánjiūjìnzhǎn |